Meet us
Virtual KOL Event on Multiple Myeloma and New Clinical Data
15. Oktober, 17:00 CEST/ 11:00 EDT
Präsentation
Annual World ADC San Diego
4. - 7. November
Präsentation
Deutsches Eigenkapitalforum
25. - 27. November
Präsentation
ASH Annual Meeting and Exposition
7. - 10. Dezember
Upcoming Conferences & Presentations 2024
Event | Date | Location |
---|---|---|
Virtual KOL Event on Multiple Myeloma and New Clinical Data
|
15. Oktober, 17:00 CEST/ 11:00 EDT
| |
Annual World ADC San Diego
|
4. - 7. November
|
San Diego
|
BIO-EUROPE
|
4. - 6. November
|
Stockholm
|
Deutsches Eigenkapitalforum
|
25. - 27. November
|
Frankfurt
|
ASH Annual Meeting and Exposition
|
7. - 10. Dezember
|
San Diego
|
Past Conferences & Presentations 2024
Event | Date | Location | Download |
---|---|---|---|
HUPO World Congress
|
20. - 24. Oktober
|
Dresden
| |
Festival of Biologics
|
15. - 17. Oktober
|
Basel
| |
16th Annual Healthcare Investor Conference
|
10. Oktober
|
London
| |
BioRN Annual Conference
|
9. Oktober
|
Heidelberg
| Download |
ADC Pharmacokinetics & Clinical Pharmacology Summit
|
8. - 10. Oktober
|
Boston
| |
21th International Myeloma Society Annual Meeting
|
25. - 28. September
|
Rio de Janeiro
| Download |
ADC Process Development Summit
|
17. - 19. September
|
Boston
| |
ESMO Congress
|
13. - 17. September
|
Barcelona
| |
LSX World Congress USA (merged with BioPharm America)
|
11. - 12. September
|
Boston
| |
ADC Pharma & Biotech Partnering Summit
|
9. - 10. September
|
Boston
| |
The Antibody Series 2024
|
4. - 6. September
|
Madeira
| |
International Symposium on Medicinal Chemistry
|
1. - 5. September
|
Rom
| |
EPS (European Peptide Symposium)
|
25. - 30. August
|
Florence
| |
GRC Natural Products and Bioactive Compounds
|
28. Juli - 2. August
|
Andover
| |
25th Conference on Global Summit on Analytical and Bioanalytical Techniques
|
24. - 25. Juli
|
Paris
|
R&D Webinar: Developing Next Generation ADCs Targeting Hard to Treat Cancers
Heidelberg Pharma will present new clinical data at an R&D webinar early next year.
Presentations are archived information about Heidelberg Pharma AG and were current at the time they were published. Archived information may have been replaced by more recent information published by the company in more recent presentations, press releases or elsewhere. The presentations and recordings may contain forward-looking statements based on management's beliefs as of the date of publication. Actual developments may differ materially from the information contained in the publications due to various factors.